—
C+
C+ The full Closelook — membership. Open the C+ overview

Fisher & Paykel Healthcare Corporation Ltd (FPH.AU) — the peer cohort

As of 2026-09-23 — scores re-bake nightly. Cohort = shared Closelook index membership first, then sector. Diary readings, not advice.

Fisher & Paykel Healthcare Corporation Ltd ranks 3 of 10 in its cohort on the Closelook composite (60/100) — the cohort is led by BB Biotech AG at 74/100.

NameCompositeMomentumQualityValuationSignalOff 52w high
FPH.AU Fisher & Paykel Healthcare Corporation Ltd 60 72 70 28 ok 4.6%
ANN.AU Ansell Ltd 63 92 47 52 ok 1%
ISRG Intuitive Surgical Inc 56 19 76 23 bull 33.4%
YPSN.SW Ypsomed Holding AG 55 66 62 30 info 14.3%
AFX.DE Carl Zeiss Meditec AG 51 54 35 58 bull 37.6%
TECN.SW Tecan Group AG 49 94 27 55 ok 1.9%
EL.PA EssilorLuxottica S. A. 45 8 47 60 bull 54.3%
RHC.AU Ramsay Health Care Ltd 44 89 23 52 ok 1%
TLX.AU TELIX Pharmaceuticals Ltd 37 71 27 17 ok 11.7%
BION.SW BB Biotech AG 74 69 96 80 info 9.6%

Scores are relative readings across the Closelook coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.

FAQ · from the current data · as of 2026-09-23

Quick answers

Who are Fisher & Paykel Healthcare Corporation Ltd's peers in the Closelook universe?

The cohort is drawn from shared Closelook index membership first, then sector: Ansell Ltd (ANN.AU), Intuitive Surgical Inc (ISRG), Ypsomed Holding AG (YPSN.SW), Carl Zeiss Meditec AG (AFX.DE), Tecan Group AG (TECN.SW), EssilorLuxottica S. A. (EL.PA), Ramsay Health Care Ltd (RHC.AU), TELIX Pharmaceuticals Ltd (TLX.AU) and others.

How does FPH.AU score against its peers?

Fisher & Paykel Healthcare Corporation Ltd's composite reads 60/100, ranking 3 of 10 in its cohort as of 2026-09-23; the cohort's highest composite is BB Biotech AG at 74/100. Closelook scores are research diary readings, not ratings or advice.

Related in the Closelook universe

then Medical Instruments & Supplies. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.